Blockchain Transaction Record
Lionheart Health Announces Additions to its Board and Leadership Team
Lionheart Health announced today additions to its board of directors and executive leadership team including Scott Hoots as co-CEO, Tessa Sphar as Onboarding Specialist for Licensees, Dr. Jwala Karnik to our Board of Directors and Chad Hacker to both Board of Directors and to our Marketing Team.
Exclusively at Newsworthy.ai — Newsworthy registers every press release distributed through this service on the blockchain so that we can provide verification services and make features such as the self-hosting of press releases available to our customers. The blockchain provides an immutable record of the press releases issued by this service. Immutability gives readers the assurance that the news they are reading has not been altered from the source document that this service distributed. We have shifted the Source of Truth to the blockchain for added protection.
Moving the Source of Truth to the blockchain improves transparency and increases trust between organizations submitting news and readers.
Key Takeaways (TLDR)
- Lionheart Health appoints Scott Hoots, Chad Hacker, Tessa Sphar, and Dr. Jwala Karnik to key positions.
- The team brings proven success in regenerative medicine, aesthetics, digital marketing, and franchise logistics.
- Focus on regenerative aesthetics and healthspan longevity drives Lionheart's innovative approach and top talent selection.
| Blockchain | Details |
|---|---|
| Chain | polygon-main |
| Transaction ID | 0xb4b8e88e17dbb1a0e2b3f37705568c95be46bd563e669a4fa6aa241709024894 |
| Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
| NWAI Digital Fingerprint | 1322-093f9d3e75e99b89ada9f5e4f5378f77 |
| Registration Timestamp | 2024-10-16T16:45:08+00:00 |
Other Recent Blockchain Registered News for Lionheart Health Inc.
- Lionheart Health Announces Patent for Bioelectric Modulation of GDF10 & BDNF for Brain and Healthspan Applications Huntington Beach, California (Newsworthy.ai) Tuesday Feb 24, 2026 @ 12:55 PM PST — Lionheart Health, Inc. announces a USPTO Letter of Allowance for its patented bioelectric technology designed to upregulate GDF10 and complementary regenerative proteins, supporting investigational applications in brain health, stroke recovery, muscle function, liver resilience, and systemic healthspan optimization.
- Lionheart Health, Inc. Proud Sponsor of Anaheim Ducks Hockey with Audio and Billboard Advertising Across All Remaining Games on Victory+ TV Huntington Beach, California (Newsworthy.ai) Tuesday Feb 10, 2026 @ 5:15 PM PST — At Lionheart Health, our mission is to translate rigorous science into practical, clinician-guided solutions that help people function better today while protecting their long-term health,” said Leslie Miller, Chief Medical Officer of Lionheart Health, Inc.
- Lionheart Health Launches Health Optimization Membership Program Huntington Beach, California (Newsworthy.ai) Tuesday Feb 10, 2026 @ 7:00 AM PST — Lionheart Health launched its Health Optimization Membership Program delivering a 461-biomarker test, clinician consultation, personalized klotho-focused protocol, discounts on 200+ products, and priority entry into the Lionheart Klotho-Up™ Study competing in the XPRIZE Healthspan competition.
- Lionheart Health and Rejuvant Partner to Compete in XPRIZE Healthspan Semi-Finals Huntington Beach, California (Newsworthy.ai) Friday Feb 6, 2026 @ 7:00 AM PST — Rejuvant’s CaAKG Supplement Becomes Core Requirement in Lionheart’s KLOTHO-UP™ Study and Klotho Wellness Program
- Lionheart Health, through Leonhardt Ventures LLC, Files Patent for Bioelectric Platform to Enhance Peptide Uptake and Longevity Therapies Huntington Beach, California (Newsworthy.ai) Tuesday Dec 30, 2025 @ 7:30 AM PST — New intellectual property spans oral, topical, and injectable peptides, with a focus on improving the efficiency of Klotho-based longevity interventions.
- Lionheart Health Files Patent for Bioelectric-Enhanced Klotho Nanoflowers Designed for Aging Reversal and Healthspan Huntington Beach, CA (Newsworthy.ai) Monday Dec 15, 2025 @ 7:00 AM PST — The newly filed patent protects a transformative therapeutic system that combines nanoflower-format nanoparticles, bioelectric signaling sequences, and Klotho-modulating biologics to target the cellular and mitochondrial drivers of aging.
- Klotho Conference 2025 Unites Global Experts to Accelerate Klotho-Based Therapies & Diagnostics Irvine, California (Newsworthy.ai) Tuesday Dec 2, 2025 @ 10:00 PM PST — The inaugural Klotho Conference & Scientific Seminar, held September 15–16 at the UCI Beall Applied Innovation Center, brought together leading researchers, clinicians, and innovators.
- Researchers at Leonhardt Ventures Unveil E-Stent™ A Breakthrough Bioelectric Stimulation Stent Tech Platform Huntington Beach, California (Newsworthy.ai) Wednesday Nov 19, 2025 @ 4:00 AM PST — Designed to control regenerative protein expressions in vessel walls and surrounding tissues for a wide range of applications.